Abstract
BackgroundAnkylosing spondylitis (AS) is associated with high risk of fractures. BMD, bone microarchitecture and strength are negatively affected in AS. TNF inhibitors such as etanercept, adalimumab, golimumab and infliximab are...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have